Table 2 Antibiotic susceptibility pattern of the ceftazidime resistant Gram negative isolates (N = 159)
Antibiotics | Enterobacteriaceae family (NÂ =Â 100) | P. aeruginosa (NÂ =Â 24) | Acinetobactercalcoac eticusbaumanii complex (NÂ =Â 35) | ||||||
|---|---|---|---|---|---|---|---|---|---|
S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | |
Amikacin | 85 | 0 | 15 | 75 | 0 | 25 | 31.4 | 2.8 | 65.7 |
Ampicillin | 0 | 0 | 100 | NT | NT | NT | NT | NT | NT |
Ampicillin–sulbactam | NT | NT | NT | NT | NT | NT | 31.4 | 2.8 | 65.7 |
Aztreonam | NT | NT | NT | 62.5 | 4.1 | 33.3 | NT | NT | NT |
Cefepime | NT | NT | NT | NT | NT | NT | 11.4 | 0 | 88.5 |
Cefotaxime | 11 | 0 | 89 | NT | NT | NT | 11.4 | 0 | 88.5 |
Ciprofloxacin | 21 | 3 | 76 | 45.8 | 0 | 54.1 | 14.2 | 2.8 | 82.8 |
Co-trimoxazole | 28 | 0 | 72 | NT | NT | NT | 31.4 | 2.8 | 65.7 |
Doxycycline | NT | NT | NT | NT | NT | NT | 34.2 | 2.8 | 62.8 |
Gentamicin | 34 | 1 | 65 | 54.1 | 0 | 45.8 | 37.1 | 0 | 62.8 |
Imipenem | NT | NT | NT | 91.6 | 0 | 8.3 | 68.5 | 5.7 | 25.7 |
Nitrofurantoin | 91 | 0 | 9 | NT | NT | NT | NT | NT | NT |
Ofloxacin | 22 | 0 | 78 | 48 | 0 | 54.1 | NT | NT | NT |
Piperacillin | NT | NT | NT | 41.6 | 0 | 58.3 | NT | NT | NT |
Piperacillin–tazobactam | NT | NT | NT | 79.1 | 0 | 20.8 | 37.1 | 0 | 62.8 |
Polymixin B | NT | NT | NT | 100 | 0 | 0 | NT | NT | NT |
Tigecycline | NT | NT | NT | NT | NT | NT | 85.7 | 0 | 14.2 |